| Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 LB Rodda, J Netland, L Shehata, KB Pruner, PA Morawski, CD Thouvenel, ... Cell 184 (1), 169-183. e17, 2021 | 709 | 2021 |
| Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 445 | 2020 |
| Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus J Marcandalli, B Fiala, S Ols, M Perotti, W de van der Schueren, J Snijder, ... Cell 176 (6), 1420-1431. e17, 2019 | 378 | 2019 |
| Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection KHD Crawford, AS Dingens, R Eguia, CR Wolf, N Wilcox, JK Logue, ... The Journal of infectious diseases 223 (2), 197-205, 2021 | 295 | 2021 |
| Adjuvanting a subunit COVID-19 vaccine to induce protective immunity PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... Nature 594 (7862), 253-258, 2021 | 271 | 2021 |
| Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle PJM Brouwer, A Antanasijevic, Z Berndsen, A Yasmeen, B Fiala, TPL Bijl, ... Nature Communications 10 (1), 4272, 2019 | 152 | 2019 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines AC Walls, MC Miranda, A Schäfer, MN Pham, A Greaney, ... Cell 184 (21), 5432-5447. e16, 2021 | 142 | 2021 |
| Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice NC Dalvie, SA Rodriguez-Aponte, BL Hartwell, LH Tostanoski, ... Proceedings of the National Academy of Sciences 118 (38), e2106845118, 2021 | 68 | 2021 |
| Discovery and engineering of enhanced SUMO protease enzymes YTK Lau, V Baytshtok, TA Howard, BM Fiala, JLM Johnson, LP Carter, ... Journal of Biological Chemistry 293 (34), 13224-13233, 2018 | 49 | 2018 |
| Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine PS Arunachalam, Y Feng, U Ashraf, M Hu, AC Walls, VV Edara, ... Science translational medicine 14 (658), eabq4130, 2022 | 35 | 2022 |
| Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice L Grigoryan, A Lee, AC Walls, L Lai, B Franco, PS Arunachalam, Y Feng, ... npj Vaccines 7 (1), 55, 2022 | 29 | 2022 |
| Stabilization of the SARS-CoV-2 spike receptor-binding domain using deep mutational scanning and structure-based design D Ellis, N Brunette, KHD Crawford, AC Walls, MN Pham, C Chen, ... Frontiers in immunology 12, 710263, 2021 | 28 | 2021 |
| Antigen-and scaffold-specific antibody responses to protein nanoparticle immunogens JC Kraft, MN Pham, L Shehata, M Brinkkemper, S Boyoglu-Barnum, ... Cell Reports Medicine 3 (10), 2022 | 22 | 2022 |
| Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge H Malhi, LJ Homad, YH Wan, B Poudel, B Fiala, AJ Borst, JY Wang, ... Cell Reports Medicine 3 (6), 2022 | 22 | 2022 |
| Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... bioRxiv, 2021.02. 10.430696, 2021 | 20 | 2021 |
| Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice AC Walls, LA VanBlargan, K Wu, A Choi, MJ Navarro, D Lee, L Avena, ... Cell Reports 40 (9), 2022 | 13 | 2022 |
| Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses S Ols, K Lenart, RA Cerveira, MC Miranda, N Brunette, J Kochmann, ... Immunity 56 (10), 2425-2441. e14, 2023 | 10 | 2023 |
| Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains JY Wang, A Khmelinskaia, W Sheffler, MC Miranda, A Antanasijevic, ... Proceedings of the National Academy of Sciences 120 (11), e2214556120, 2023 | 7 | 2023 |
| Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region CT Schoeder, P Gilchuk, AK Sangha, KV Ledwitch, DC Malherbe, ... PLoS pathogens 18 (5), e1010518, 2022 | 7 | 2022 |
| Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection (medRxiv) KHD Crawford, AS Dingens, R Eguia, CR Wolf, N Wilcox, JK Logue, ... Published online August 7, 2020.08, 2020 | 5 | 2020 |
